Guest guest Posted November 2, 2011 Report Share Posted November 2, 2011 News 6 new results for hepatitis c Regulus Therapeutics Expands Worldwide Patent Coverage on microRNA-122 to ...MarketWatch (press release)In February 2010, Regulus and GlaxoKline entered into a new collaboration to develop and commercialize microRNA therapeutics targeting microRNA-122 for the treatment of hepatitis C infection. Regulus is advancing multiple other microRNA ...See all stories on this topic » Get rid of hepatitis with herbsNigerian TribuneThe route of transmission of hepatitis C is not completely clear but is believed to be similar to that of hepatitis B. When an individual first develop hepatitis, it is called acute hepatitis. Hepatitis can also become a long-term disease known as ...See all stories on this topic » Medivir Announces Final Results from TMC435 Phase IIb ASPIRE (C206) StudySacramento BeeThis phase IIb study evaluated TMC435 once daily in addition to pegylated interferon (PegIFN) and ribavirin (RBV) in patients with genotype-1 chronic hepatitis C whose prior treatment with PegIFN and RBV was unsuccessful either because they relapsed, ...See all stories on this topic » Pharmasset shares continue rise on PhIII plan for interferon-free PSI-7977FierceBiotechAnd the biotech ($VRUS) has whipped up a slate of late-stage trials for PSI-7977, a darling of the investment community, which clearly comprehends the blockbuster market that awaits any hepatitis C treatment that doesn't require injections of ...See all stories on this topic » Vertex Riding High on Incivek SalesInvestorIdeas.com (press release)Increased revenues from the sale of hepatitis C virus (HCV) treatment, Incivek (telaprevir) helped record positive earnings. Riding on the strong sales of Incivek, which was launched in the second quarter of 2011, Vertex Pharma reported total revenue ...See all stories on this topic » OraSure Technologies Inc. says third-quarter loss rose after DNA Genotek ...The Express Times - LehighValleyLive.comOraSure applied for a waiver to expand use of its rapid Hepatitis C test to include sale to doctor's offices. The company's Hepatitis C test is now restricted to lab use. "Obviously profitability will depend on how quickly we get those products out and ...See all stories on this topic » The Express Times - LehighValleyLive.com - more news http://health.dir./group/ /links/025___HCV_DAILY_NEWS_RESOURCES_001268599268/ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.